Medtronic plc.

Open: 80.0 Close: 79.61 Change: -0.39

Don't invest before reading what an AI found about Medtronic plc. Company Inc Stock.

This document will help you to evaluate Medtronic plc. without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, MDT, device, CGM, Simplera, market, Medtronics, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Diabetes is a high-grossing indication for Medtronic. The consensus analyst rating on MDT is a Buy.

Today's News

Level Four Advisory Services LLCs holdings in Medtronic were worth $4,389,000 at the end of the most recent reporting period. The company recently disclosed a quarterly dividend payout ratio (DPR) of 101.85%. Medtronic has received a CE mark for its continuous glucose monitoring (CGM) device, Simplera, allowing the device to be marketed in the European Union. Diabetes is a high-grossing indication for Medtronics, it generated $556m in Q2 2023. Medtronic plc (mdt) stock price, quote, news & analysis. Share price: MDT (MDT) closed $11.75 below its 52-week high ($92.02) Medtronic plc (MDT) Valuation Measures & Financial Statistics. markets close in 2 hours 35 minutes S&P 500 4,328.48 +8.42 +842 (+0.42%) Dow 30 33,945.95 -17.89 (-0.89%) Nasdaq 13,245.73 +33.92 (+10.39%) Russell 2000 1,786 89 ( Medtronic plc (mdt) latest stock news & headlines - yahoo finance. medtronic. Latest Stock News & Headlines - Yahoo Finance Home Mail News Finance Sports Entertainment Search Mobile. Medtronic stopped sale and distribution of the HeartWare Ventricular Assist Device (HVAD) system on June 3, 2021. Medtronics Urgent Medical Device communication describes a newly identified subgroup of HVAD pumps that have a higher risk of failure to restart than the general population of patients with HvAD pumps. The FDA continues to work to ensure the health and safety of device users. Medtronic announces Simplera CGM with disposable-in-one design for new Simplera. Smart MDI system is the first to seamlessly integrate real-time CGM and smart insulin pen powered by an adjustable algorithm. Abbott is the top Medtronic competitor and alternative. Stryker is one of the top competitors for Medtronics. DePuy Synthes offers orthopedic and neurosurgery devices, which compete against Medtron. J&J is a formidable competitor for Meds. Medtronic PLC MDT, -0.67% slid 1.39% to $81.48 Wednesday, on what proved to be an all-around grim trading for the stock market. The consensus analyst rating on MDT is a Buy.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

How much time have you spent trying to decide whether investing in Medtronic plc.? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, MDT, device, CGM, Simplera, market, Medtronics, and the most common words in the summary are: medtronic, stock, mdt, market, plc, top, job, . One of the sentences in the summary was: The consensus analyst rating on MDT is a Buy.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #mdt #market #plc #top #job.